相关实验视频

Updated: Sep 14, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

乳腺癌异质性如何确定液中瘤标志物水平的变化?

Elena I Dyachenko¹, Lyudmila V Bel'skaya¹

¹Biochemistry Research Laboratory, Omsk State Pedagogical University, 644099 Omsk, Russia.

Current issues in molecular biology

|July 23, 2025

概括

唾液瘤标志物水平在乳腺癌亚型之间有显著差异. 这一发现突出了唾液.

科学领域:

在瘤学瘤学.
生物化学生物化学
分子生物学分子生物学

背景情况:

乳腺癌具有很高的异质性,使分子亚型和诊断复杂化.
癌症患者的静脉切割可能具有挑战性,需要使用替代的诊断方法.

研究的目的:

为了研究不同乳腺癌分子亚型的唾液瘤标记物变异.
评估唾液作为乳腺癌标志物分析的诊断液的潜力.

主要方法:

一项涉及110名乳腺癌患者和30名健康对照者的病例控制研究.
在治疗前采集的唾液样本使用ELISA分析了十种瘤标记物 (EGFR2,CA15-3,CA27.29,MCA,CEA,CA125,CA19-9,CYFRA 21-1,费里丁,CRP).

主要成果:

MUC1抗原 (CA15-3,CA27.29,MCA) 在光线B(+) 亚型下降.
CA19-9对低HER2表达有敏感性.
CYFRA 21-1在光线A和光线B的亚型中增加;CRP仅在光线A中增加.
在亚型之间观察到瘤标志物概况的显著差异.

结论:

唾液分析揭示了乳腺癌分子亚型的独特瘤标记模式.
唾液显示出用于非侵入性监测乳腺癌标志物的诊断潜力.

关键词:

CA125 CA125 CA125 CA125 是一家在美国的公司.在CA19-9的CA19-9的CA19-9的CA19-9 在 CEA CEA 中.在CRP中使用CRP.在CYFRA 21-1中使用.在MUC1中,MUC1是MUC1.乳腺癌乳腺癌乳腺癌皮肤表皮生长因子受体 (HER2)费里氨酸 (Ferritin) 是一种铁素.这是唾液,唾液.

更多相关视频

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement EFIRM

Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement EFIRM

Published on: January 23, 2015

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...